Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
17 March 2016
Header
Header image
Highlight of the week

Highlight of the week

IMI ADAPT SMART Podcast on Managed Entry Agreements
17 March 2016

ADAPT SMART is an enabling platform for the coordination of Medicines Adaptive Pathways to Patients (MAPPs) activities. MAPPs seeks to foster access to beneficial treatments for the right patient groups at the earliest appropriate time in the product life-span, in a sustainable fashion.

ADAPT SMART will support IMI2 projects investigating MAPPs tools and methodologies, and will engage in a dialogue with all relevant stakeholders to prove and develop workable MAPPs concepts.

EFPIA is a participant in the ADAPT SMART consortium.

LISTEN TO THE FULL PODCAST 

Read more

From our blog

From our blog

Charting Our Route towards HCP Disclosure
17 March 2016 by Faraz Kermani

The success and spread of the internet, coupled with increasing demands on health services, has empowered patients to take more proactive role and interest in how their healthcare is delivered. As patients become more engaged, consequently their demand for more data, details and information need to be satisfied.

Read more

Events calendar

Events Calendar

EFPIA Annual Conference 2016
On 15/06/2016 (Radisson Hotel, Brussels)

This year's EFPIA Annual Conference will take place on 15 June 2016, at the Radisson Hotel in Brussels. The event will examine the challenges faced by healthcare systems in Europe, the exciting science that will play a key role in meeting these challenges and the long-term sustainability of healthcare delivery. An interactive exhibition will be set up to provide attendees with further insight into EFPIA’s current initiatives, which aim at facilitating a pan-European dialogue on the importance of shifting towards a model of outcomes-driven healthcare.
 
The final programme can be accessed here
 
Read more

Events Calendar

2016 China/EU Pharmaceutical Industry Forum
On 05/04/2016 (Hamburg, Germany)

CPIA and EFPIA will organise a workshop on 5 April 2016, in Hamburg, Germany, with the following areas of focus: an overview of the pharmaceutical market in China/EU; Pharmaceuticals in the Environment; the Drug Administration Law (DAL) revision; and the implementation of new EU legislation. 

The workshop takes place the day before the start of the DIA Euro meeting, which will facilitate for those who already plan to attend the DIA Euro meeting in Hamburg.
 
This will be an excellent opportunity to listen to e.g. a presentation on the revision of the Drug Administration Law in China and the European Commission strategy for Pharmaceuticals in the Environment (PIE) and also get direct information from the Commission on what will happen in 2019 re Identification and authentication of medicines in Europe as a result of the implementation of the Falsified Medicines Directive.
 
Please see the programmme for further details. Below, you can access the speakers' presentations:
 
European Commission strategy for Pharmaceuticals in the Environment (PIE), Patrizia Tosetti, Medical products: quality, safety, innovation, European Commission
 
 
Read more

Events Calendar

EFGCP Multi-Stakeholder Workshop & Discussion on How to Ensure Optimal Ethical Review within the New Clinical Trials Regulation? Where do we currently stand with the implementation in different Member States
On 13/04/2016 (Brussels)

Organised by EFGCP with the partnership of EORTC

A revision of the Clinical Trials Regulation was adopted by European legislation makers in 2014. This revised legal framework will bring significant advances compared with today’s situation and is expected to be fully implemented as soon as the supporting Clinical Trials Portal and Database are fully functional (2H2017).

For more information about the programme, please click here.

Read more

Events Calendar

DIA 28th Annual EuroMeeting 2016
From 06/04/2016 to 08/04/2016 (Hamburg, Germany)

In a world in which new therapies are being developed at a phenomenal rate, is innovation always the answer?

The DIA EuroMeeting is the premier platform on which to exchange ideas with thought leaders on key challenges and opportunities facing health care product development professionals. 

By attending EuroMeeting 2016, you will discuss issues while building relationships with your regulatory, industry and academia counterparts who are guiding the trends.

DOWNLOAD PROGRAMME

Read more

Events Calendar

ICH Info Day (this event is part of the pre-conference programme of the DIA EuroMeeting)
On 06/04/2016 (Hamburg, Germany)

This year’s Information Day will focus on the recent reforms within ICH and what this means for the global development of medicines. Participants will hear how ICH is moving towards becoming a truly global platform for regulators and industry, in order to achieve the objective of ‘Harmonisation for Better Health’.

Learn directly from the experts: 
Sessions include Q&A with: Dawn Ronan, Director of the ICH Secretariat; Tomas Salmonson EMA; and Richard Bergström, EFPIA, Belgium 

Read more

Documents

From our blog

Enhancing Value in European Health Systems: The Role of Outcomes Measurement - Consensus Document
15 March 2016 (Publications)

Health systems across the European Union are confronting numerous challenges – from ageing populations and the sustainable financing of health care, to wide variations in [...] Read more

From our blog

IPROVE report: A Strategic European Roadmap for the Vaccines of Tomorrow: a Joint Stakeholder Reflection
17 March 2016 (Publications)

The Innovation Partnership for a Roadmap on Vaccines in Europe (IPROVE) represents a collaborative effort by the leading vaccine experts in Europe to develop a [...] Read more

What we are reading

What we are reading

Advancing diagnosis of dementia
17 March 2016 (The Centre for Dementia Prevention i)

It is now widely recognised that the key to tackling conditions like dementia lies in earlier diagnosis and preventative treatment. The advances of 21st century medicine allow us to move on from keeping people alive for longer, towards keeping people healthy for longer.

Read more

What we are reading

How to enhance the value Europe gets from its healthcare expenditure
17 March 2016 (Science|Business)

Across Europe, there are marked inequalities in health outcomes: in 2012, the gap in life expectancy between the highest and lowest performing European countries was 8.5 years.

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail